These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20123466)

  • 1. Executive function in early-treated phenylketonuria: profile and underlying mechanisms.
    Christ SE; Huijbregts SC; de Sonneville LM; White DA
    Mol Genet Metab; 2010; 99 Suppl 1():S22-32. PubMed ID: 20123466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria.
    Huijbregts SC; Gassió R; Campistol J
    Mol Genet Metab; 2013; 110 Suppl():S25-30. PubMed ID: 24206933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R; Sullivan K; Young R; McGill J
    Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R; Sullivan K; Young R; McGill J
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychology of early-treated phenylketonuria: specific executive function deficits.
    Welsh MC; Pennington BF; Ozonoff S; Rouse B; McCabe ER
    Child Dev; 1990 Dec; 61(6):1697-713. PubMed ID: 2083493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is BRIEF a useful instrument in day to day care of patients with phenylketonuria?
    Liemburg GB; Jahja R; van Spronsen FJ; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; Huijbregts SC
    Mol Genet Metab; 2015 Mar; 114(3):425-30. PubMed ID: 25541101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond executive function: non-executive cognitive abilities in individuals with PKU.
    Janzen D; Nguyen M
    Mol Genet Metab; 2010; 99 Suppl 1():S47-51. PubMed ID: 20123470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.
    Sharman R; Sullivan KA; Young RM; McGill JJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S417-20. PubMed ID: 20882350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
    Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
    Diamond A
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.
    Hood A; Grange DK; Christ SE; Steiner R; White DA
    Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
    Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
    Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU.
    Christ SE; Clocksin HE; Burton BK; Grant ML; Waisbren S; Paulin MC; Bilder DA; White DA; Saville C
    Neuropsychology; 2020 May; 34(4):456-466. PubMed ID: 32202818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.